Pharmaceuticals Give Large Sums of Money to Physicians
Most patients are unaware that different pharmaceutical companies give doctors thousands of dollars for each patient that they enrol in experimental drug trials. Even though the motive’s of the...
View ArticleVytorin Maker Settles Lawsuits
Merck, the drug maker, announced this week that it would payout over $688 million to settle lawsuits brought by its shareholders, including a number of pension funds that alleged large sums of money...
View ArticleAmgen Stops Trial for Drug after Teen Dies
The U.S. Food and Drug Administration on Tuesday announced it had stopped all clinical pediatric trials for Sensipar an Amgen, Inc. drug following the death of a patient who was 14 years old, who had...
View ArticleJustice Department Settles Online Pharmacy Probe with UPS
The U.S. Justice Department announced it had reached an agreement for $40 million Friday to settle charges against UPS that the giant shipping company had done business with Internet pharmacies that...
View ArticleHealthcare Sector Leads Wall Street Increase
Stocks increased Tuesday, which was headed by the healthcare sector. The rally came after the government announced its decision on payment rates. Investors also felt optimistic after the release of the...
View ArticleEarnings Down Beat for Merck
Merck, the giant pharmaceutical maker missed its earnings target during the first three months of 2013. At first glance, earnings jumped 85 cents a share, which exceeded estimates from Wall Street...
View ArticleActavis to acquire Warner Chilcott
Actavis, the generic drug maker, has been talked about over speculation of being taken over, is planning to buy Ireland’s Warner Chilcott the specialty pharmaceutical firm for a price of $5 billion....
View ArticleTenet Acquiring Vanguard Health in Deal for $1.8 Billion
Vanguard Health Systems, a hospital operator, will be acquired by Tenet Healthcare Corp, for an estimated $1.8 billion so Tenet can expand into more hospitals in Texas. The deal will have Tenet paying...
View ArticleHospital Chain Tenet Acquires Vanguard Health
Tenet Healthcare, a US hospital operator, announced that it will acquire its rival Vanguard Health Systems for $1.73 billion. It would give it a better position to benefit from President Barack Obama’s...
View ArticleExecutives of British Drug Maker Investigated for Bribes
The police in China announced on Monday that British pharmaceutical giant GlaxoSmithKline had channeled millions of dollars worth of bribes through travel agents in China to doctors and government...
View ArticleActelion Reaches High of Six Years
Actelion the Swiss biotech company saw its shares climb over 5% to their highest since 2007 on Monday. Its stock prices increased on optimism that it had a viable product to gain sales and earn profit...
View ArticleProfit Falls at Merck on Lower Sales
Merck and Co’s earnings for the third quarter dropped by 35% as it lost the exclusivity for Singulair the allergy and asthma drug that contributed to the pharmaceutical giant’s weaker sales. Merck said...
View ArticlePfizer Beats Wall Street Estimates
Pfizer, Inc., the biggest drug maker in the world reported profits for the third quarter that passed the estimates of analysts as the drug maker lowered its costs, while its sales of its top painkiller...
View ArticleJohnson & Johnson to Pay Penalty of $2.2 Billion
Johnson & Johnson agreed it would pay over $2.2 billion in order to settle civil and criminal claims that it had marketed Risperdal, its antipsychotic drug as well as other medications for uses...
View ArticleShire to Acquire ViroPharma for $4.2 Billion
Shire, based in Dublin announced on Monday that it had agreed to acquire ViroPharma for $4.2 billion to expand its rare disease treatments portfolio. The company said it agreed to pay $50 a share for...
View ArticleGlaxoSmithKline Stops Paying Doctors for Promotion of Drugs
GlaxoSmithKline the British pharmaceutical giant announced on Tuesday that it was stopping its payments to doctors who speak on behalf of the company. GSK also announced that pay for sales...
View ArticleProfit at Merck Falls in Fourth Quarter
Merck, the pharmaceutical giant based in Whitehouse Station, New Jersey, announced that profits fell in the fourth quarter of 2012 by 7%. Company officials said that was due in part to sales of...
View ArticlePharmaceuticals Give Large Sums of Money to Physicians
Most patients are unaware that different pharmaceutical companies give doctors thousands of dollars for each patient that they enrol in experimental drug trials. Even though the motive’s of the...
View ArticleCVS Caremark Profit Increase by 12% in Fourth Quarter
Shares at CVS Caremark outpaced Tuesday’s broader market after the pharmacy chain increased its forecast for earnings for the beginning of 2014 and reassured its investors that its business could...
View ArticleFewer Generic Drugs Hit Profit at Walgreens
On Tuesday, Walgreen Co. reported a quarterly profit that was lower than had been expected. This was due in part to a slowdown in the number of new generic medicines that are high profit being...
View Article
More Pages to Explore .....